The Ring Pro returns to the U.S. market with a redesigned unibody metal structure, longer battery life and improved on-device processing, and pre-orders open with shipping slated to begin mid-May 2026, starting at $399 (early bird $349 for the first 1,000 buyers).

Core health tracking remains subscription-free, while advanced features like AFib detection, ovulation tracking, and migraine insights are available as optional paid PowerPlugs.

The ecosystem includes a simplified package option with just the mini charger and an independently sold charging case.

CEO Mohit Kumar brings scale-up experience from Zomato and Roadrunnr, but the company faces execution risk in a litigious hardware landscape.

Kumar remains optimistic that engineers will drive meaningful product-led progress and biomarker breakthroughs over the next decade.

Industry observers say Ultrahuman must demonstrate ecosystem value and broaden exclusive features to compete, especially if unibody designs become a standard.

Kumar frames a patent battle as strategic by Oura to block competitors, while Ultrahuman focuses on engineering and product innovation over litigation.

Long-term ambition includes discovering a new health biomarker—potentially lactate—and leveraging a broader ecosystem to differentiate from rivals like Oura.

Future directions point to new wearables targeting different biomarkers, continued emphasis on manufacturing execution, legal clarity, and turning sensor data into actionable insights.